209 related articles for article (PubMed ID: 33983594)
1. Multigene Panel Testing for Hereditary Cancer and Genetic Counseling.
Lee ES; Kim J; Han W
Adv Exp Med Biol; 2021; 1187():455-471. PubMed ID: 33983594
[TBL] [Abstract][Full Text] [Related]
2. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
[TBL] [Abstract][Full Text] [Related]
3. Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
Tsaousis GN; Papadopoulou E; Apessos A; Agiannitopoulos K; Pepe G; Kampouri S; Diamantopoulos N; Floros T; Iosifidou R; Katopodi O; Koumarianou A; Markopoulos C; Papazisis K; Venizelos V; Xanthakis I; Xepapadakis G; Banu E; Eniu DT; Negru S; Stanculeanu DL; Ungureanu A; Ozmen V; Tansan S; Tekinel M; Yalcin S; Nasioulas G
BMC Cancer; 2019 Jun; 19(1):535. PubMed ID: 31159747
[TBL] [Abstract][Full Text] [Related]
4. Psychosocial Effects of Multigene Panel Testing in the Context of Cancer Genomics.
Hamilton JG; Robson ME
Hastings Cent Rep; 2019 May; 49 Suppl 1(Suppl 1):S44-S52. PubMed ID: 31268573
[TBL] [Abstract][Full Text] [Related]
5. Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain.
Esteban I; Vilaró M; Adrover E; Angulo A; Carrasco E; Gadea N; Sánchez A; Ocaña T; Llort G; Jover R; Cubiella J; Servitja S; Herráiz M; Cid L; Martínez S; Oruezábal-Moreno MJ; Garau I; Khorrami S; Herreros-de-Tejada A; Morales R; Cano JM; Serrano R; López-Ceballos MH; González-Santiago S; Juan-Fita MJ; Alonso-Cerezo C; Casas A; Graña B; Teulé A; Alba E; Antón A; Guillén-Ponce C; Sánchez-Heras AB; Alés-Martínez JE; Brunet J; Balaguer F; Balmaña J
Psychooncology; 2018 Jun; 27(6):1530-1537. PubMed ID: 29498768
[TBL] [Abstract][Full Text] [Related]
6. Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.
Graffeo R; Livraghi L; Pagani O; Goldhirsch A; Partridge AH; Garber JE
Breast Cancer Res Treat; 2016 Dec; 160(3):393-410. PubMed ID: 27734215
[TBL] [Abstract][Full Text] [Related]
7. Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2.
Minion LE; Dolinsky JS; Chase DM; Dunlop CL; Chao EC; Monk BJ
Gynecol Oncol; 2015 Apr; 137(1):86-92. PubMed ID: 25622547
[TBL] [Abstract][Full Text] [Related]
8. An update on genetic risk assessment and prevention: the role of genetic testing panels in breast cancer.
Piccinin C; Panchal S; Watkins N; Kim RH
Expert Rev Anticancer Ther; 2019 Sep; 19(9):787-801. PubMed ID: 31469018
[No Abstract] [Full Text] [Related]
9. Inherited Cancer in the Age of Next-Generation Sequencing.
Price KS; Svenson A; King E; Ready K; Lazarin GA
Biol Res Nurs; 2018 Mar; 20(2):192-204. PubMed ID: 29325452
[TBL] [Abstract][Full Text] [Related]
10. Genetic risk assessment and prevention: the role of genetic testing panels in breast cancer.
Lerner-Ellis J; Khalouei S; Sopik V; Narod SA
Expert Rev Anticancer Ther; 2015; 15(11):1315-26. PubMed ID: 26523341
[TBL] [Abstract][Full Text] [Related]
11. Updates in hereditary breast cancer genetic testing and practical high risk breast management in gene carriers.
Pederson HJ; Noss R
Semin Oncol; 2020 Aug; 47(4):182-186. PubMed ID: 32513422
[TBL] [Abstract][Full Text] [Related]
12. Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients.
Crawford B; Adams SB; Sittler T; van den Akker J; Chan S; Leitner O; Ryan L; Gil E; van 't Veer L
Breast Cancer Res Treat; 2017 Jun; 163(2):383-390. PubMed ID: 28281021
[TBL] [Abstract][Full Text] [Related]
13. Update on multi-gene panel testing and communication of genetic test results.
Reid S; Pal T
Breast J; 2020 Aug; 26(8):1513-1519. PubMed ID: 32639074
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of laboratory perspectives on hereditary cancer panels.
Stoll J; Weissman SM; Hook N; Selkirk C; Johnson AK; Newlin A; Vogel Postula KJ
Fam Cancer; 2016 Oct; 15(4):689-96. PubMed ID: 26869169
[TBL] [Abstract][Full Text] [Related]
15. Multi-gene Panel Testing in Breast Cancer Management.
Fountzilas C; Kaklamani VG
Cancer Treat Res; 2018; 173():121-140. PubMed ID: 29349761
[TBL] [Abstract][Full Text] [Related]
16. Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer.
Kapoor NS; Curcio LD; Blakemore CA; Bremner AK; McFarland RE; West JG; Banks KC
Ann Surg Oncol; 2015 Oct; 22(10):3282-8. PubMed ID: 26219241
[TBL] [Abstract][Full Text] [Related]
17. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
18. Universal Genetic Testing for All Breast Cancer Patients.
Copur MS
Oncology (Williston Park); 2019 Aug; 33(8):. PubMed ID: 31469901
[TBL] [Abstract][Full Text] [Related]
19. Next-generation sequencing for inherited breast cancer risk: counseling through the complexity.
Rainville IR; Rana HQ
Curr Oncol Rep; 2014 Mar; 16(3):371. PubMed ID: 24488544
[TBL] [Abstract][Full Text] [Related]
20. Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective study.
Brédart A; Kop JL; Dick J; Cano A; De Pauw A; Anota A; Brunet J; Devilee P; Stoppa-Lyonnet D; Schmutzler R; Dolbeault S
BMJ Open; 2019 Sep; 9(9):e029926. PubMed ID: 31551380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]